An old drug called spironolactone opens the door to a new generation of more effective Epstein-Barr virus drugs that could help with chronic fatigue syndrome, long COVID and other diseases.
A couple of weeks ago Health Rising posted a kind of wakeup call for the COVID-19 long haulers. Borne out of decades of experience with ME/CFS, it was admittedly a pretty harsh piece – not easy to take in. An Open Letter to the COVID-19 Long Hauler Community...
“If you look anecdotally, there is no question that there are a considerable number of individuals who have a post-viral syndrome that in many respects incapacitates them for weeks and weeks following so-called recovery. They report symptoms such as brain fog,...
High rates of alterations in the genes that produce mucosal proteins suggest that a damaged mucous layer in the eyes, nose or upper respiratory systems of people with chronic fatigue syndrome could be providing pathogens or toxins easier entry - possibly producing neuroinflammation and central sensitization.
Keep the information flowing! Support Health Rising during our end of the year fundraising drive. Click here for more.
Stay Up to Date with ME/CFS, Long COVID and Fibromyalgia News
Get Health Rising's free blogs featuring the latest findings and treatment options for the ME/CFS, long COVID, fibromyalgia and complex chronic disease communities.